Tracey McCain
Oficial de Cumplimiento en BLUEPRINT MEDICINES CORPORATION .
Fortuna: 6 M $ al 30/04/2024
Cargos activos de Tracey McCain
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Oficial de Cumplimiento | 06/09/2016 | - |
| Consejero General | 06/09/2016 | - | |
| Secretario Corporativo | 06/09/2016 | - | |
| KINIKSA PHARMACEUTICALS, LTD. | Director/Miembro de la Junta | 01/02/2018 | - |
| Independent Dir/Board Member | 01/02/2018 | - |
Historial de carrera de Tracey McCain
Antiguos cargos conocidos de Tracey McCain.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| IMMUNOGEN, INC. | Director/Miembro de la Junta | 15/11/2021 | 12/02/2024 |
| Independent Dir/Board Member | 15/11/2021 | 12/02/2024 | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Consejero General | 01/01/2016 | 02/09/2016 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Consejero General | 01/05/1997 | 01/09/2016 |
| Palmer & Dodge LLP | Corporate Officer/Principal | - | - |
Formación de Tracey McCain.
| University of Pennsylvania | Undergraduate Degree |
| Columbia Law School | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 8 |
| Reino Unido | 2 |
Operativa
| General Counsel | 3 |
| Director/Board Member | 2 |
| Independent Dir/Board Member | 2 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| Palmer & Dodge LLP | Commercial Services |
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Tracey McCain
- Experiencia
